News
-
-
COMMUNIQUÉ DE PRESSE
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update
TuHURA Biosciences, Inc. provides a business update on its innovative cancer immunotherapy technologies, including IFx-2.0 Phase 3 trial for Merkel Cell Carcinoma, potential KVA12123 acquisition, and key management appointments -
-
-
COMMUNIQUÉ RÉGLEMENTÉ
TERACT - Modalités de mise à disposition des documents préparatoires à l’Assemblée générale mixte du 16 décembre 2024
Annonce des modalités de mise à disposition des documents pour l'Assemblée générale mixte du 16 décembre 2024. Les actionnaires peuvent consulter les documents sur le site internet de la Société -
COMMUNIQUÉ RÉGLEMENTÉ
Statement of transactions in own shares from November 18, 2024 to November 22, 2024
-
COMMUNIQUÉ RÉGLEMENTÉ
Déclaration des transactions sur actions propres réalisées du 18/11/2024 au 22/11/2024
-
-
COMMUNIQUÉ DE PRESSE
EQ Inc. Reports Third Quarter Financial Results
EQ Works reports significant improvements in adjusted EBITDA sequentially and year over year with revenue holding steady, gross margin increasing, and successful cost optimization efforts driving profitability. Company secures financing and legal settlement inflow supports financial position -
COMMUNIQUÉ DE PRESSE
Grande Portage Resources Files 2025 Plan of Operation/Drill Permit for the New Amalga Gold Property in S.E. Alaska
Grande Portage Resources Ltd. announces filing of 2025 Plan of Operation for New Amalga Mine Gold project in Alaska, featuring diamond drilling and exploration activities
